Islay Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Islay Capital Management's PFE Position: Q1 2026 in Review
Islay Capital Management reduced its Pfizer (PFE) stake by 84% in Q1 2026, selling an estimated $27.6K and leaving 200 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #174.
Islay Capital Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $119K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Islay Capital Management held 200 shares of Pfizer worth $5.62K as of Q1 2026.
- Islay Capital Management sold 1,036 Pfizer shares in Q1 2026, an estimated $27.6K.
- Pfizer made up ﹤0.01% of Islay Capital Management's portfolio in Q1 2026, its #174 holding.
- Islay Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
- Islay Capital Management's Pfizer position peaked at $119K in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Islay Capital Management's 13F filing for Q1 2026, filed 14 May 2026.